Homeostatic proliferation ensures the longevity of central memory T-cells by inducing cell proliferation in the absence of cellular differentiation or activation. This process is governed mainly by IL-7. Central memory T-cells can also be stimulated via engagement of the T-cell receptor, leading to cell proliferation but also activation and differentiation. Using an in vitro model of HIV-1 latency, we have examined in detail the effects of homeostatic proliferation on latently infected central memory T cells. We have also used antigenic stimulation via anti-CD3/anti-CD28 antibodies and established a comparison with a homeostatic proliferation stimulus, to evaluate potential differences in how either treatment affects the dynamics of latent virus populations. First, we show that homeostatic proliferation, as induced by a combination of IL-2 plus IL-7, leads to partial reactivation of latent HIV-1 but is unable to reduce the size of the reservoir in vitro. Second, latently infected cells are able to homeostatically proliferate in the absence of viral reactivation or cell differentiation. These results indicate that IL-2 plus IL-7 may induce a detrimental effect by favoring the maintenance of the latent HIV-1 reservoir. On the other hand, antigenic stimulation efficiently reactivated latent HIV-1 in cultured central memory cells and led to depletion of the latently infected cells via virus-induced cell death.
Vyšlo v časopise: Homeostatic Proliferation Fails to Efficiently Reactivate HIV-1 Latently Infected Central Memory CD4+ T Cells. PLoS Pathog 7(10): e32767. doi:10.1371/journal.ppat.1002288 Kategorie: Research Article prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002288
1. RichmanDDMargolisDMDelaneyMGreeneWCHazudaD 2009 The challenge of finding a cure for HIV infection. Science 323 1304 1307
2. ChunTWStuyverLMizellSBEhlerLAMicanJA 1997 Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 94 13193 13197
3. FinziDHermankovaMPiersonTCarruthLMBuckC 1997 Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278 1295 1300
4. TronoDVan LintCRouziouxCVerdinEBarre-SinoussiF 2010 HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science 329 174 180
5. ShenLSilicianoRF 2008 Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol 122 22 28
6. SallustoFLenigDForsterRLippMLanzavecchiaA 1999 Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 708 712
7. ZhuJYamaneHPaulWE 2010 Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28 445 489
8. BoymanOPurtonJFSurhCDSprentJ 2007 Cytokines and T-cell homeostasis. Curr Opin Immunol 19 320 326
9. MichieCAMcLeanAAlcockCBeverleyPC 1992 Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360 264 265
10. ToughDFSprentJ 1994 Turnover of naive - and memory-phenotype T cells. J Exp Med 179 1127 1135
11. SurhCDSprentJ 2008 Homeostasis of naive and memory T cells. Immunity 29 848 862
12. SeddonBTomlinsonPZamoyskaR 2003 Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 4 680 686
13. PersaudDZhouYSilicianoJMSilicianoRF 2003 Latency in human immunodeficiency virus type 1 infection: no easy answers. J Virol 77 1659 1665
14. DouekDCPickerLJKoupRA 2003 T cell dynamics in HIV-1 infection. Annu Rev Immunol 21 265 304
15. ChomontNEl-FarMAncutaPTrautmannLProcopioFA 2009 HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15 893 900
16. BosqueAPlanellesV 2009 Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood 113 58 65
17. MessiMGiacchettoINagataKLanzavecchiaANatoliG 2003 Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 4 78 86
18. BosqueAPlanellesV 2011 “Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells”. Methods 53 54 61
19. WangFXXuYSullivanJSouderEArgyrisEG 2005 IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J Clin Invest 115 128 137
20. LehrmanGYlisastiguiLBoschRJMargolisDM 2004 Interleukin-7 induces HIV type 1 outgrowth from peripheral resting CD4+ T cells. J Acquir Immune Defic Syndr 36 1103 1104
21. Scripture-AdamsDDBrooksDGKorinYDZackJA 2002 Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol 76 13077 13082
22. AndersenJLDeHartJLZimmermanESArdonOKimB 2006 HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. PLoS Pathog 2 e127
23. ScholzenTGerdesJ 2000 The Ki-67 protein: from the known and the unknown. J Cell Physiol 182 311 322
24. Gondois-ReyFBiancottoAPionMChenineALGluschankofP 2001 Production of HIV-1 by resting memory T lymphocytes. AIDS 15 1931 1940
25. JordanABisgroveDVerdinE 2003 HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. Embo J 22 1868 1877
26. DuvergerAJonesJMayJBibollet-RucheFWagnerFA 2009 Determinants of the establishment of human immunodeficiency virus type 1 latency. J Virol 83 3078 3093
27. SeretiIDunhamRMSpritzlerJAgaEProschanMA 2009 IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 113 6304 6314
28. YangHCXingSShanLO'ConnellKDinosoJ 2009 Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest 119 3473 86
29. ArchinNMEspesethAParkerDCheemaMHazudaD 2009 Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses 25 207 212
30. LahmHWSteinS 1985 Characterization of recombinant human interleukin-2 with micromethods. J Chromatogr 326 357 361
31. SimmMShahabuddinMChaoWAllanJSVolskyDJ 1995 Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J Virol 69 4582 4586
32. SchmidIColeSWKorinYDZackJAGiorgiJV 2000 Detection of cell cycle subcompartments by flow cytometric estimation of DNA-RNA content in combination with dual-color immunofluorescence. Cytometry 39 108 116
33. VandegraaffNKumarRHockingHBurkeTRJrMillsJ 2001 Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase. Antimicrob Agents Chemother 45 2510 2516
34. ButlerSLHansenMSBushmanFD 2001 A quantitative assay for HIV DNA integration in vivo. Nat Med 7 631 634
Zvýšte si kvalifikáciu online z pohodlia domova
Nemáte účet? Registrujte sa
Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
